LFST Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

378.05M

+16.14%

-0.008

-58%

381.48M

+14.57%

-0.000

-98.5%

Estimates Revision

The market is revising Upward the revenue expectations for LifeStance Health Group, Inc. (LFST) for FY2025, with the revenue forecasts being adjusted by 0.4% over the past three months. During the same period, the stock price has changed by 38.06%.

Revenue Estimates for FY2025

Revise Upward

+0.4%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-82.97%

In Past 3 Month

Stock Price

Go Up

+38.06%

In Past 3 Month

5 Analyst Rating

Wall Street analysts forecast LFST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFST is 9.00 USD with a low forecast of 8.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

0 Hold

0 Sell

Strong Buy

Current: 0.000

Low

8.00

Averages

9.00

High

10.00

Current: 0.000

Low

8.00

Averages

9.00

High

10.00

Canaccord

Richard Close

Buy

maintain

$8 -> $9

2026-01-08

New

Reason

Canaccord

Richard Close

Price Target

$8 -> $9

2026-01-08

New

maintain

Buy

Reason

Canaccord analyst Richard Close raised the firm's price target on LifeStance to $9 from $8 and keeps a Buy rating on the shares. The firm updated its model to reflect opportunity amid an uncertain healthcare environment while the company could be insulated from much of the uncertainty in broader healthcare ecosystem, with payers continuing to be supportive of expanding in-network access to care.

BTIG

Buy

maintain

$9 -> $10

2025-12-12

Reason

BTIG

Price Target

$9 -> $10

2025-12-12

maintain

Buy

Reason

BTIG raised the firm's price target on LifeStance to $10 from $9 and keeps a Buy rating on the shares. Heading into 2026 we believe that medical utilization will remain high driven by a healthy labor market, rising specialty and oncology Rx demand, new specialty medications coming to market, more demand for mental health services, and increases in post-acute utilization - all macro factors expected to benefit LifeStance, the analyst tells investors in a research note.

BMO Capital

Outperform

initiated

2025-11-12

Reason

BMO Capital

Price Target

2025-11-12

initiated

Outperform

Reason

BMO Capital initiated coverage of LifeStance with an Outperform rating and $8 price target. With new initiatives in place to boost growth, attention has turned to their effectiveness, the analyst tells investors in a research note. LifeStance's focus is shifting from solely adding clinicians to also enhancing their productivity, while expanding into specialty care offers additional upside, the firm says, adding that the stock appears attractively valued.

UBS

Buy

maintain

$9 -> $10

2025-11-07

Reason

UBS

Price Target

$9 -> $10

2025-11-07

maintain

Buy

Reason

UBS raised the firm's price target on LifeStance to $10 from $9 and keeps a Buy rating on the shares. LifeStance posted a solid beat across the board for Q3 and raised its fiscal 2025 profit outlook, the analyst tells investors in a research note.

UBS

Buy

maintain

2025-08-08

Reason

UBS

Price Target

2025-08-08

maintain

Buy

Reason

UBS raised the firm's price target on LifeStance to $9 from $8.50 and keeps a Buy rating on the shares.

BTIG

Buy

initiated

2025-07-25

Reason

BTIG

Price Target

2025-07-25

initiated

Buy

Reason

BTIG initiated coverage of LifeStance with a Buy rating and $8 price target. The firm says LifeStance is one of the country's largest outpatient mental health providers. It notes that 90% of the company's patients are commercially insured, making it well networked into health systems and referring hospitals. BTIG believes commercially insured lives are the most attractive segment of the market since insurance rates are typically well above Medicare and Medicaid rates. LifeStance is differentiated given its in-person and virtual care model, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for LifeStance Health Group Inc (LFST.O) is 239.18, compared to its 5-year average forward P/E of -2.90. For a more detailed relative valuation and DCF analysis to assess LifeStance Health Group Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-2.90

Current PE

239.18

Overvalued PE

95.08

Undervalued PE

-100.88

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

44.61

Current EV/EBITDA

17.29

Overvalued EV/EBITDA

77.96

Undervalued EV/EBITDA

11.26

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

2.93

Current PS

1.72

Overvalued PS

5.17

Undervalued PS

0.70

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 132.67% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 132.67% over the last month.

Sold

Bought

LFST News & Events

Events Timeline

No data

News

9.0

2025-12-26Benzinga

Biohaven Ltd's Depression Drug Trial Fails to Meet Primary Endpoint, Shares Plunge 14.3%

2.0

2025-12-24Benzinga

SeaStar Medical Announces 1-for-10 Reverse Split, Shares Drop 9.5%

6.0

2025-11-13Benzinga

BMO Capital Begins Coverage of LifeStance Health Group with Outperform Rating and Sets Price Target at $8

People Also Watch

Frequently Asked Questions

What is LifeStance Health Group Inc (LFST) stock price today?

The current price of LFST is 7.4 USD — it has increased 0.27 % in the last trading day.

What is LifeStance Health Group Inc (LFST)'s business?

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

What is the price predicton of LFST Stock?

What is LifeStance Health Group Inc (LFST)'s revenue for the last quarter?

LifeStance Health Group Inc revenue for the last quarter amounts to 363.81M USD, increased 16.34 % YoY.

What is LifeStance Health Group Inc (LFST)'s earnings per share (EPS) for the last quarter?

LifeStance Health Group Inc. EPS for the last quarter amounts to 0.00 USD, decreased -100.00 % YoY.

What changes have occurred in the market's expectations for LifeStance Health Group Inc (LFST)'s fundamentals?

How many employees does LifeStance Health Group Inc (LFST). have?

LifeStance Health Group Inc (LFST) has 10218 emplpoyees as of January 10 2026.

What is LifeStance Health Group Inc (LFST) market cap?

Today LFST has the market capitalization of 2.88B USD.